Zhang Y, Proenca R, Maffei M, Barone M, Leopold L,
Friedman JM. Positional cloning of the mouse obese gene
and its human homologue. Nature 1994; 372(6505): 425-
[DOI: 10.1038/372425a0]
Chaldakov G, Fiore M, Ghenev P, Stankulov IS, Aloe L.
Atherosclerotic lesions: Possible interactive involvement of
intima, adventitia and associated adipose tissue. In Med J
; 7:43-49.
Chaldakov G, Stankulov I, Hristova M, Ghenev P.
Adipobiology of disease: Adipokines and adipokine-targeted
pharmacology. Curr Pharm Des 2003; 9:1023-1031.
[DOI: 10.2174/1381612033455152]
Chaldakov G, Fiore M, Tonchev A, Dimitrov D, Pancheva
R, Rancic G, et al. Homo obesus: A metabotrophindeficient
species. Pharmacology and nutrition insight.
Curr Pharm Des 2007; 13:2176-2179. [DOI: 10.2174/
Astrup A, Finer N. Redefining Type 2 diabetes: ‘Diabesity’
or ‘Obesity Dependent Diabetes Mellitus’? Obesity Rev 2000;
(2): 57-59. [DOI: 10.1046/j.1467-789x.2000.00013.x]
Farag YM, Gaballa MR. Diabesity: an overview of a rising
epidemic. Nephrol Dial Transplant 2011; 26(1): 28-35.
[DOI: 10.1093/ndt/gfq576]
Aloe L, Tonchev AB, Fiore M, Chaldakov GN. Homo diabesus:
involvement of metabotrophic factors. Adipobiology
; 5(45-49. [DOI: 10.14748/adipo.v5.297]
Naderali EK, Ratcliffe SH, Dale MC. Review: Obesity and
Alzheimer’s disease: A link between body weight and cognitive
function in old age. Am J Alzheimer’s Dis Other Demen
; 24(6): 445-449. [DOI: 10.1177/1533317509348208]
Frisardi V, Solfrizzi V, Seripa D, Capurso C, Santamato A,
Sancarlo D, et al. Metabolic-cognitive syndrome: A crosstalk
between metabolic syndrome and Alzheimer’s disease.
Ageing Res Rev 2010; 9(4): 399-417. [DOI: 10.1016/j.
arr.2010.04.007]
Forny-Germano L, De Felice FG, Vieira MNdN. The Role
of Leptin and Adiponectin in Obesity-Associated Cognitive
Decline and Alzheimer’s Disease. Front Neurosci 2019;
(1027). [DOI: 10.3389/fnins.2018.01027]
Chaldakov G. Human body as a multicrine system, with
special reference to cell protein secretion: from vascular
smooth muscles to adipose tissue. Adipobiology 2017; 8:
-17. [DOI: 10.14748/adipo.v8.2089]
Töre F, Tonchev A, Fiore M, Tunçel N, Atanassova P,
Aloe L, et al. From Adipose Tissue Protein Secretion to
Adipopharmacology
of Disease. Immunol Endocr Metab
Agents Med Chem 2007; 7:149-155. [DOI: 10.2174/
Rodríguez A, Becerril S, Ezquerro S, Méndez-Giménez L,
Frühbeck G. Crosstalk between adipokines and myokines
in fat browning. Acta Physiol 2017; 219(2): 362-381. [DOI:
1111/apha.12686]
Calton EK, Soares MJ, James AP, Woodman RJ. The potential
role of irisin in the thermoregulatory responses to mild
cold exposure in adults. Am J Hum Biol 2016; 28(5): 699-
[DOI: 10.1002/ajhb.22853]
Renes J, Rosenow A, Mariman E. Novel adipocyte features
discovered by adipoproteomics. Adipobiology 2009; 1: 7-18.
[DOI: 10.14748/adipo.v1.245]
Renes J, Mariman E. Application of proteomics technology
in adipocyte biology. Mol Biosyst 2013; 9(6): 1076-1091.
[DOI: 10.1039/c3mb25596d]
Broholm C, Pedersen BK. Leukaemia inhibitory factor--an
exercise-induced myokine. Exerc Immunol Rev 2010; 16:
-85.
Matthews VB, Aström MB, Chan MH, Bruce CR, Krabbe
KS, Prelovsek O, et al. Brain-derived neurotrophic factor is
produced by skeletal muscle cells in response to contraction
and enhances fat oxidation via activation of AMP-activated
protein kinase. Diabetologia 2009; 52(7): 1409-1418. [DOI:
1007/s00125-009-1364-1]
Pedersen BK, Pedersen M, Krabbe KS, Bruunsgaard H,
Matthews VB, Febbraio MA. Role of exercise-induced brainderived
neurotrophic factor production in the regulation of
energy homeostasis in mammals. Exp Physiol 2009; 94(12):
-1160. [DOI: 10.1113/expphysiol.2009.048561]
Matsakas A, Foster K, Otto A, Macharia R, Elashry MI,
Feist S, et al. Molecular, cellular and physiological investigation
of myostatin propeptide-mediated muscle growth
in adult mice. Neuromuscul Disord 2009; 19(7): 489-499.
[DOI: 10.1016/j.nmd.2009.06.367]
Schering L, Hoene M, Kanzleiter T, Jähnert M, Wimmers
K, Klaus S, et al. Identification of novel putative adipomyokines
by a cross-species annotation of secretomes and
expression profiles. Arch Physiol Biochem 2015; 121(5):
-205. [DOI: 10.3109/13813455.2015.1092044]
Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM.
Natriuretic peptides: their structures, receptors, physiologic
functions and therapeutic applications. Handbook Exp
Pharmacol 2009;191:341-366. [DOI: 10.1007/978-3-540-
-5_15]
Görgens SW, Eckardt K, Jensen J, Drevon CA, Eckel
J. Exercise and Regulation of Adipokine and Myokine
Production. Prog Mol Biol Transl Sci 2015; 135: 313-336.
[DOI: 10.1016/bs.pmbts.2015.07.002]
Li F, Li Y, Duan Y, Hu CA, Tang Y, Yin Y. Myokines and
adipokines: Involvement in the crosstalk between skeletal
muscle and adipose tissue. Cytokine Growth Factor Rev
; 33: 73-82. [DOI: 10.1016/j.cytogfr.2016.10.003]
Raschke S, Eckel J. Adipo-myokines: two sides of the
same coin--mediators of inflammation and mediators of
exercise. Mediators Inflamm 2013; 2013(320724. [DOI:
1155/2013/320724]
Trayhurn P, Drevon CA, Eckel J. Secreted proteins from
adipose tissue and skeletal muscle - adipokines, myokines
and adipose/muscle cross-talk. Arch Physiol Biochem 2011;
(2): 47-56. [DOI: 10.3109/13813455.2010.535835]
Oh KJ, Lee DS, Kim WK, Han BS, Lee SC, Bae KH.
Metabolic adaptation in obesity and type II diabetes:
Myokines, adipokines and hepatokines. Int J Mol Sci 2016;
(1). [DOI: 10.3390/ijms18010008]
Chung HS, Choi KM. Adipokines and myokines: A pivotal
role in metabolic and cardiovascular disorders. Curr Med
Chem 2018; 25(20): 2401-2415. [DOI: 10.2174/0929867325
Kirk B, Feehan J, Lombardi G, Duque G. Muscle, bone, and
fat crosstalk: the biological role of myokines, osteokines,
and adipokines. Curr Osteopor Rep 2020; 18(4): 388-400.
[DOI: 10.1007/s11914-020-00599-y]
Xiang L, Xiang G, Yue L, Zhang J, Zhao L. Circulating irisin
levels are positively associated with endothelium-dependent
vasodilation in newly diagnosed type 2 diabetic patients
without clinical angiopathy. Atherosclerosis 2014; 235(2):
-333. [DOI: 10.1016/j.atherosclerosis.2014.04.036]
Sesti G, Andreozzi F, Fiorentino TV, Mannino GC, Sciacqua
A, Marini MA, et al. High circulating irisin levels are associated
with insulin resistance and vascular atherosclerosis
in a cohort of nondiabetic adult subjects. Acta Diabetol
; 51(5): 705-713. [DOI: 10.1007/s00592-014-0576-0]
Ozturk G, Demirel O, Tekatas A, Celebi C, Avci B, Gurel
EE, et al. Circulating irisin levels in newly diagnosed obstructive
sleep apnea patients. Scr Sci Med 2019; 51(1): 16-
[DOI: 10.14748/ssm.v51i1.5908]
Hofmann T, Elbelt U, Stengel A. Irisin as a muscle-derived
hormone stimulating thermogenesis – A critical
update. Peptides 2014; 54: 89-100. [DOI: 10.1016/j.peptides.
01.016]
Gamas L, Matafome P, Seiça R. Irisin and Myonectin
Regulation in the Insulin Resistant Muscle: Implications
to Adipose Tissue: Muscle Crosstalk. J Diab Res 2015;
(359159-359159. [DOI: 10.1155/2015/359159]
Kurdiova T, Balaz M, Vician M, Maderova D, Vlcek M,
Valkovic L, et al. Effects of obesity, diabetes and exercise on
Fndc5 gene expression and irisin release in human skeletal
muscle and adipose tissue: in vivo and in vitro studies. J
Physiol 2014; 592(5): 1091-1107. [DOI: 10.1113/jphysiol.
264655]
Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh
JY, Park KH, Seufert J, et al. Physiology and role of irisin in
glucose homeostasis. Nat Rev Endocrinol 2017; 13(6): 324-
[DOI: 10.1038/nrendo.2016.221]
Moreno-Navarrete JM, Ortega F, Serrano M, Guerra E,
Pardo G, Tinahones F, et al. Irisin is expressed and produced
by human muscle and adipose tissue in association
with obesity and insulin resistance. J Clin Endocrinol Metab
; 98(4): E769-778. [DOI: 10.1210/jc.2012-2749]
Aydin S, Aydin S, Kobat MA, Kalayci M, Eren MN, Yilmaz
M, et al. Decreased saliva/serum irisin concentrations in the
acute myocardial infarction promising for being a new candidate
biomarker for diagnosis of this pathology. Peptides
; 56: 141-145. [DOI: 10.1016/j.peptides.2014.04.002]
Zhu D, Wang H, Zhang J, Zhang X, Xin C, Zhang F, et
al. Irisin improves endothelial function in type 2 diabetes
through reducing oxidative/nitrative stresses. J Mol
Cell Cardiol 2015; 87: 138-147. [DOI: 10.1016/j.yjmcc.
07.015]
Hou N, Han F, Sun X. The relationship between circulating
irisin levels and endothelial function in lean and obese
subjects. Clin Endocrinol 2014; 83: 339-343. [DOI: 10.1111/
cen.12658]
Park KH, Zaichenko L, Brinkoetter M, Thakkar B, Sahin-
Efe A, Joung KE, et al. Circulating irisin in relation to
insulin resistance and the metabolic syndrome. J Clin
Endocrinol Metab 2013; 98(12): 4899-4907. [DOI: 10.1210/
jc.2013-2373]
More CE, Papp C, Harsanyi S, Gesztelyi R, Mikaczo A,
Tajti G, et al. Altered irisin/BDNF axis parallels excessive
daytime sleepiness in obstructive sleep apnea patients.
Respir Res 2019; 20(1): 67-67. [DOI: 10.1186/s12931-019-
-y]
Yang D, Yang Y, Li Y, Han R. Physical Exercise as Therapy
for Type 2 Diabetes Mellitus: From Mechanism to
Orientation. Ann Nutr Metab 2019; 74(4): 313-321. [DOI:
1159/000500110]
Martinez-Huenchullan SF, Tam CS, Ban LA, Ehrenfeld-
Slater P, McLennan SV, Twigg SM. Skeletal muscle adiponectin
induction in obesity and exercise. Metabolism
; 102(154008. [DOI: 10.1016/j.metabol.2019.154008]
Kadowaki T, Yamauchi T, Kubota N, Hara K, Ueki K, Tobe
K. Adiponectin and adiponectin receptors in insulin resistance,
diabetes, and the metabolic syndrome. J Clin Inves
; 116(7): 1784-1792. [DOI: 10.1172/JCI29126]
Yu N, Ruan Y, Gao X, Sun J. Systematic Review and Meta-
Analysis of Randomized, Controlled Trials on the Effect of
Exercise on Serum Leptin and Adiponectin in Overweight
and Obese Individuals. Horm Metab Res 2017; 49(3): 164-
[DOI: 10.1055/s-0042-121605]
Öztürk G, Kaya O, Gürel EE, Palabiyik O, Kunduracilar
H, Süt N, et al. Acute supramaximal exercise-induced
adiponectin increase in healthy volunteers: Involvement
of natriuretic peptides. Adipobiology 2017; 8: 9-45. [DOI:
14748/adipo.v8.2092]
Levi-Montalcini R. The nerve growth factor 35 years later.
Science 1987; 237(4819): 1154-1162. [DOI: 10.1126/science.
Rocco ML, Soligo M, Manni L, Aloe L. Nerve growth
factor: Early studies and recent clinical trials. Curr
Neuropharmacol 2018; 16(10): 1455-1465. [DOI: 10.2174/
x16666180412092859]
Chaldakov GN, Fiore M, Stankulov IS, Manni L, Hristova
MG, Antonelli A, et al. Neurotrophin presence in human
coronary atherosclerosis and metabolic syndrome: a role
for NGF and BDNF in cardiovascular disease? Prog Brain
Res 2004; 146: 279-289.
Sornelli F, Fiore M, Chaldakov GN, Aloe L. Adipose tissue-
derived nerve growth factor and brain-derived neurotrophic
factor: results from experimental stress and diabetes.
Gen Physiol Biophys 2009; 28:179-183.
Yanev S, Aloe L, Fiore M, Chaldakov GN. Neurotrophic
and metabotrophic potential of nerve growth factor and
brain-derived neurotrophic factor: Linking cardiometabolic
and neuropsychiatric diseases. World J Pharmacol 2013;
(4): 92-99. [DOI:10.5497/wjp.v2.i4.92]
Yanev S, Fiore M, Hinev A, Ghenev P, Hristova M,
Panayotov P, et al. From antitubulins to trackins. Biomed
Rev 2016; 27: 59-67. [DOI: 10.14748/bmr.v27.2112]
Carito V, Venditti A, Bianco A, Ceccanti M, Serrilli A,
Chaldakov G, et al. Effects of olive leaf polyphenols on male
mouse brain NGF, BDNF and their receptors TrkA, TrkB
and p75. Natural Product Res 2014; 28: 1970-1984 [DOI:
1080/14786419.2014.918977]
Fang W, Zhang J, Hong L, Huang W, Dai X, Ye Q, et al.
Metformin ameliorates stress-induced depression-like
behaviors via enhancing the expression of BDNF by activating
AMPK/CREB-mediated histone acetylation. J
Affective Disord 2020; 260: 302-313. [DOI: 10.1016/j.
jad.2019.09.013]
Oliveira F, Mamede M, Bizzi M, Rocha AL, Ferreira C,
Gomes K, et al. Effects of Short Term Metformin Treatment
on Brown Adipose Tissue Activity and Plasma Irisin Levels
in Women with Polycystic Ovary Syndrome: A Randomized
Controlled Trial. Horm Metab Res 2020; 52: 718-723. [DOI:
1055/a-1157-0615]
Tsai S-J. Statins May Act Through Increasing Tissue
Plasminogen Activator/Plasmin Activity to Lower Risk of
Alzheimer’s Disease. CNS Spectrums 2009; 14: 234-235.
[DOI: 10.1017/S1092852900025360]
Sridhar GR: Encode, decode and diabetes. In: Cognitive
Science and Health Bioinformatics: Advances and
Applications. Singapore: Springer Singapore, 2018; 47-55.
Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush
J, et al. The secreted protein discovery initiative (SPDI),
a large-scale effort to identify novel human secreted and
transmembrane proteins: a bioinformatics assessment.
Genome Res 2003; 13(10): 2265-2270. [DOI: 10.1101/
gr.1293003]
Chaldakov GN, Vankov VN. Morphological aspects of secretion
in the arterial smooth muscle cell, with special reference
to the Golgi complex and microtubular cytoskeleton.
Atherosclerosis 1986; 61(3): 175-192. [DOI: 10.1016/0021-
(86)90137-1]
De Franco E, Lytrivi M, Ibrahim H, Montaser H, Wakeling
MN, Fantuzzi F, et al. YIPF5 mutations cause neonatal diabetes
and microcephaly through endoplasmic reticulum
stress. J Clin Invest 2020. [DOI: 10.1172/jci141455]
Chaldakov GN. Colchicine, a microtubule-disassembling
drug, in the therapy of cardiovascular diseases. Cell Biol Int
; 42(8): 1079-1084. [DOI: 10.1002/cbin.10988]
Arhire LI, Mihalache L, Covasa M. Irisin: A hope in understanding
and managing obesity and metabolic syndrome.
Front Endocrinol (Lausanne) 2019; 10: 524. [DOI: 10.3389/
fendo.2019.00524]
Frohlich J, Chaldakov GN, Vinciguerra M. Cardio- and neurometabolic
adipobiology: Consequences and implications
for therapy. Int J Mol Sci 2021; 22(8): 4137. [DOI:10.3390/
ijms22084137]
Chaldakov GN, Aloe A, Rancic G, Pancheva RZ, Hiriart
M, Fiore M, Yanev S. Chapter 16. The Relevance of
Metabotrophic Factors in Pathobiology and Therapy of
Obesity and Related Diseases. In: P.S. Tappia et al. (eds.),
Cellular and Biochemical Mechanisms of Obesity, Advances
in Biochemistry in Health and Disease 23. Springer Nature
Switzerland AG 2021. [DOI:10.1007/978-3-030-84763-
_16]
Email this article (Login required) 
